Figure legends
Figure 1. The
change (reduction) in viral load from baseline on day 3 and day 5 in
patients with mild to moderate COVID-19 treated with Azvudine or
placebo. (A) Patients with viral load ≥ 3log10 copies/ml. (B) Patients
with viral load ≥ 4log10 copies/ml. The P values indicated the
differences in the change (reduction) in viral load from baseline on day
5 between the Azvudine group and placebo group.